Literature DB >> 23479725

MicroRNA-584 and the protein phosphatase and actin regulator 1 (PHACTR1), a new signaling route through which transforming growth factor-β Mediates the migration and actin dynamics of breast cancer cells.

Nadège Fils-Aimé1, Meiou Dai, Jimin Guo, Mayada El-Mousawi, Bora Kahramangil, Jean-Charles Neel, Jean-Jacques Lebrun.   

Abstract

TGF-β plays an important role in breast cancer progression as a prometastatic factor, notably through enhancement of cell migration. It is becoming clear that microRNAs, a new class of small regulatory molecules, also play crucial roles in mediating tumor formation and progression. We found TGF-β to down-regulate the expression of the microRNA miR-584 in breast cancer cells. Furthermore, we identified PHACTR1, an actin-binding protein, to be positively regulated by TGF-β in a miR-584-dependent manner. Moreover, we found TGF-β-mediated down-regulation of miR-584 and increased expression of PHACTR1 to be required for TGF-β-induced cell migration of breast cancer cells. Indeed, both overexpression of miR-584 and knockdown of PHACTR1 resulted in a drastic reorganization of the actin cytoskeleton and reduced TGF-β-induced cell migration. Our data highlight a novel signaling route whereby TGF-β silences the expression of miR-584, resulting in enhanced PHACTR1 expression, and further leading to actin rearrangement and breast cancer cell migration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23479725      PMCID: PMC3636869          DOI: 10.1074/jbc.M112.430934

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  79 in total

Review 1.  TGFbeta signaling in growth control, cancer, and heritable disorders.

Authors:  J Massagué; S W Blain; R S Lo
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  TGF-beta signaling: positive and negative effects on tumorigenesis.

Authors:  Lalage M Wakefield; Anita B Roberts
Journal:  Curr Opin Genet Dev       Date:  2002-02       Impact factor: 5.578

Review 3.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 4.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

Review 5.  The two faces of transforming growth factor beta in carcinogenesis.

Authors:  Anita B Roberts; Lalage M Wakefield
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-14       Impact factor: 11.205

6.  Inhibition of transforming growth factor beta signaling in MCF-7 cells results in resistance to tumor necrosis factor alpha: a role for Bcl-2.

Authors:  S W Tobin; M K Brown; K Douville; D C Payne; A Eastman; B A Arrick
Journal:  Cell Growth Differ       Date:  2001-02

Review 7.  Manipulation of TGF-beta to control autoimmune and chronic inflammatory diseases.

Authors:  W Chen; S M Wahl
Journal:  Microbes Infect       Date:  1999-12       Impact factor: 2.700

Review 8.  TGF-beta signaling in tumor suppression and cancer progression.

Authors:  R Derynck; R J Akhurst; A Balmain
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

Review 9.  Tumour-cell invasion and migration: diversity and escape mechanisms.

Authors:  Peter Friedl; Katarina Wolf
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

10.  MicroRNA targets in Drosophila.

Authors:  Anton J Enright; Bino John; Ulrike Gaul; Thomas Tuschl; Chris Sander; Debora S Marks
Journal:  Genome Biol       Date:  2003-12-12       Impact factor: 13.583

View more
  28 in total

1.  Myocardial Infarction-Associated SNP at 6p24 Interferes With MEF2 Binding and Associates With PHACTR1 Expression Levels in Human Coronary Arteries.

Authors:  Mélissa Beaudoin; Rajat M Gupta; Hong-Hee Won; Ken Sin Lo; Ron Do; Christopher A Henderson; Claire Lavoie-St-Amour; Simon Langlois; Daniel Rivas; Stephanie Lehoux; Sekar Kathiresan; Jean-Claude Tardif; Kiran Musunuru; Guillaume Lettre
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-02       Impact factor: 8.311

2.  Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection.

Authors:  Stéphanie Debette; Yoichiro Kamatani; Tiina M Metso; Manja Kloss; Ganesh Chauhan; Stefan T Engelter; Alessandro Pezzini; Vincent Thijs; Hugh S Markus; Martin Dichgans; Christiane Wolf; Ralf Dittrich; Emmanuel Touzé; Andrew M Southerland; Yves Samson; Shérine Abboud; Yannick Béjot; Valeria Caso; Anna Bersano; Andreas Gschwendtner; Maria Sessa; John Cole; Chantal Lamy; Elisabeth Medeiros; Simone Beretta; Leo H Bonati; Armin J Grau; Patrik Michel; Jennifer J Majersik; Pankaj Sharma; Ludmila Kalashnikova; Maria Nazarova; Larisa Dobrynina; Eva Bartels; Benoit Guillon; Evita G van den Herik; Israel Fernandez-Cadenas; Katarina Jood; Michael A Nalls; Frank-Erik De Leeuw; Christina Jern; Yu-Ching Cheng; Inge Werner; Antti J Metso; Christoph Lichy; Philippe A Lyrer; Tobias Brandt; Giorgio B Boncoraglio; Heinz-Erich Wichmann; Christian Gieger; Andrew D Johnson; Thomas Böttcher; Maurizio Castellano; Dominique Arveiler; M Arfan Ikram; Monique M B Breteler; Alessandro Padovani; James F Meschia; Gregor Kuhlenbäumer; Arndt Rolfs; Bradford B Worrall; Erich-Bernd Ringelstein; Diana Zelenika; Turgut Tatlisumak; Mark Lathrop; Didier Leys; Philippe Amouyel; Jean Dallongeville
Journal:  Nat Genet       Date:  2014-11-24       Impact factor: 38.330

3.  Association of a transcription factor 21 gene polymorphism with hypertension.

Authors:  Tetsuo Fujimaki; Mitsutoshi Oguri; Hideki Horibe; Kimihiko Kato; Reiko Matsuoka; Shintaro Abe; Fumitaka Tokoro; Masazumi Arai; Toshiyuki Noda; Sachiro Watanabe; Yoshiji Yamada
Journal:  Biomed Rep       Date:  2014-10-13

4.  MicroRNA-584 functions as a tumor suppressor and targets PTTG1IP in glioma.

Authors:  Xiang-Peng Wang; Xing-Li Deng; Li-Yan Li
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

Review 5.  Review article epithelial to mesenchymal transition‑associated microRNAs in breast cancer.

Authors:  Hossein Javdani; Homa Mollaei; Farzaneh Karimi; Shiva Mahmoudi; Ali Farahi; Mohamad Javad Mirzaei-Parsa; Arman Shahabi
Journal:  Mol Biol Rep       Date:  2022-06-18       Impact factor: 2.742

6.  Phactr1 negatively regulates bone mass by inhibiting osteogenesis and promoting adipogenesis of BMSCs via RhoA/ROCK2.

Authors:  Wei Lin; Zhipeng Chen; Xiaoyi Mo; Shengli Zhao; Zhenxing Wen; Wing Hoi Cheung; Dan Fu; Bailing Chen
Journal:  J Mol Histol       Date:  2021-10-28       Impact factor: 3.156

7.  Common pathways and functional profiles reveal underlying patterns in Breast, Kidney and Lung cancers.

Authors:  Sergio Romera-Giner; Zoraida Andreu Martínez; Francisco García-García; Marta R Hidalgo
Journal:  Biol Direct       Date:  2021-05-26       Impact factor: 4.540

8.  The Early-Onset Myocardial Infarction Associated PHACTR1 Gene Regulates Skeletal and Cardiac Alpha-Actin Gene Expression.

Authors:  Annina Kelloniemi; Zoltan Szabo; Raisa Serpi; Juha Näpänkangas; Pauli Ohukainen; Olli Tenhunen; Leena Kaikkonen; Elina Koivisto; Zsolt Bagyura; Risto Kerkelä; Margret Leosdottir; Thomas Hedner; Olle Melander; Heikki Ruskoaho; Jaana Rysä
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

Review 9.  From genotype to phenotype in human atherosclerosis--recent findings.

Authors:  Lesca M Holdt; Daniel Teupser
Journal:  Curr Opin Lipidol       Date:  2013-10       Impact factor: 4.776

10.  Complex Interplay of Genes Underlies Invasiveness in Fibrosarcoma Progression Model.

Authors:  Michaela Kripnerová; Hamendra Singh Parmar; Jiří Šána; Alena Kopková; Lenka Radová; Sieghart Sopper; Krzysztof Biernacki; Jan Jedlička; Michaela Kohoutová; Jitka Kuncová; Jan Peychl; Emil Rudolf; Miroslav Červinka; Zbyněk Houdek; Pavel Dvořák; Kateřina Houfková; Martin Pešta; Zdeněk Tůma; Martina Dolejšová; Filip Tichánek; Václav Babuška; Martin Leba; Ondřej Slabý; Jiří Hatina
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.